BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21761228)

  • 1. Postoperative prophylactic effect of fondaparinux for prevention of deep venous thrombosis after cemented total hip replacement: a comparative study.
    Kawaji H; Ishii M; Tamaki Y; Hamasaki M; Ishikawa H; Sasaki K; Dairaku K; Takagi M
    Mod Rheumatol; 2012 Apr; 22(2):216-22. PubMed ID: 21761228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and time course of asymptomatic deep vein thrombosis with fondaparinux in patients undergoing total joint arthroplasty.
    Yamaguchi T; Hasegawa M; Niimi R; Sudo A
    Thromb Res; 2010 Oct; 126(4):e323-6. PubMed ID: 20451962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of fondaparinux on the diagnosis of postoperative deep vein thrombosis by soluble fibrin and D-dimer.
    Niimi R; Hasegawa M; Shi DQ; Sudo A
    Thromb Res; 2012 Nov; 130(5):759-64. PubMed ID: 22192153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of bone cement application on the incidence of deep vein thrombosis in major joint arthroplasties].
    Aslan A; Ağar E; Aydoğan NH; Atay T; Baydar ML; Kırdemir V; Ozden A
    Eklem Hastalik Cerrahisi; 2011 Dec; 22(3):149-54. PubMed ID: 22085350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of graduated compression stockings in association with fondaparinux in surgery of the hip. A multicentre, multinational, randomised, open-label, parallel-group comparative study.
    Cohen AT; Skinner JA; Warwick D; Brenkel I
    J Bone Joint Surg Br; 2007 Jul; 89(7):887-92. PubMed ID: 17673580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep venous thrombosis after mini-posterior total hip arthroplasty in Japanese patients.
    Ishibe M; Kariya S
    Hip Int; 2011; 21(6):684-7. PubMed ID: 22101618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial.
    Turpie AG; Bauer KA; Eriksson BI; Lassen MR;
    Lancet; 2002 May; 359(9319):1721-6. PubMed ID: 12049860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison.
    Lassen MR; Bauer KA; Eriksson BI; Turpie AG;
    Lancet; 2002 May; 359(9319):1715-20. PubMed ID: 12049858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombophylaxis with low-dose, short-term fondaparinux after elective hip surgery.
    Tsuda K; Nishii T; Sakai T; Takao M; Nakamura N; Sugano N
    J Thromb Thrombolysis; 2016 Apr; 41(3):413-21. PubMed ID: 26184606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery.
    Turpie AG; Eriksson BI; Lassen MR; Bauer KA
    J South Orthop Assoc; 2002; 11(4):182-8. PubMed ID: 12597061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fondaparinux for prevention of venous thromboembolism in major orthopedic surgery.
    Tran AH; Lee G
    Ann Pharmacother; 2003 Nov; 37(11):1632-43. PubMed ID: 14565815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism prophylaxis: role of factor xa inhibition by fondaparinux.
    Turpie AG
    Surg Technol Int; 2004; 13():261-7. PubMed ID: 15744699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study on the efficacies of fondaparinux and enoxaparin in preventing venous thromboembolism after hip fracture surgery.
    Sasaki S; Miyakoshi N; Matsuura H; Saito H; Nakanishi T; Kudo Y; Fujiya T; Shimada Y
    J Orthop Sci; 2011 Jan; 16(1):64-70. PubMed ID: 21293896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of combined modality prophylaxis including short-duration warfarin to prevent venous thromboembolism after total hip arthroplasty.
    Keeney JA; Clohisy JC; Curry MC; Maloney WJ
    J Arthroplasty; 2006 Jun; 21(4):469-75. PubMed ID: 16781396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective randomized controlled trial on the effect of fondaparinux sodium for prevention of venous thromboembolism after hip fracture surgery.
    Sasaki S; Miyakoshi N; Matsuura H; Saitoh H; Kudoh D; Shimada Y
    J Orthop Sci; 2009 Sep; 14(5):491-6. PubMed ID: 19802659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk factor for residual deep vein thrombosis after fondaparinux administration in patients with postoperative replacement arthroplasty].
    Enokiya T; Muraki Y; Iwamoto T; Kawase R; Hasegawa M; Sudo A; Uchida A; Okuda M
    Yakugaku Zasshi; 2012; 132(5):683-7. PubMed ID: 22687701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New pentasaccharides for the prophylaxis of venous thromboembolism: clinical studies.
    Turpie AG; Eriksson BI; Bauer KA; Lassen MR
    Chest; 2003 Dec; 124(6 Suppl):371S-378S. PubMed ID: 14668420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery.
    Agnelli G; Bergqvist D; Cohen AT; Gallus AS; Gent M;
    Br J Surg; 2005 Oct; 92(10):1212-20. PubMed ID: 16175516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose TB-402 or rivaroxaban for the prevention of venous thromboembolism after total hip replacement. A randomised, controlled trial.
    Verhamme P; Gunn S; Sonesson E; Peerlinck K; Vanassche T; Vandenbriele C; Ageno W; Glazer S; Prins M; Buller H; Tangelder M
    Thromb Haemost; 2013 Jun; 109(6):1091-8. PubMed ID: 23615791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.